Vimarsana
Biggest News Aggregation in the World

Page 2 - Anthony Doyle News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anthony Doyle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anthony Doyle Today - Breaking & Trending Today

LINKTV Democracy Now March 28, 2014 - Vimarsana News

LINKTV Democracy Now March 28, 2014

Legal architects of the agencys secret programs after 9 11. Hasnt been tortured. As a lawyer, we have a certain standard and other people have their own moral beliefs about what is torture, but had it been torture, as a lawyer, that would have ended it right then and there. Today, john rizzo, former acting general counsel of the cia versus human rights attorney and law professor scott horton. All of that and more coming up. This is democracy now , democracynow. Org, the war and peace report. Im amy goodman. The United Nations General Assembly has voted to reject russias annexation of crimea fr...

Wicklow students and Tidy Towns revitalise local laneway with eco-conscious murals - Vimarsana News

Wicklow students and Tidy Towns revitalise local laneway with eco-conscious murals

After weeks of hard work and dedication, transition year students from Arklow CBS recently unveiled a series of creative and eco-conscious murals that have revitalised a busy local laneway.

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) CFO Anthony Doyle Acquires 36,300 Shares of Stock - Vimarsana News

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) CFO Anthony Doyle Acquires 36,300 Shares of Stock

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) CFO Anthony Doyle bought 36,300 shares of the stock in a transaction on Tuesday, May 14th. The stock was purchased at an average cost of $5.57 per share, for a total transaction of $202,191.00. Following the acquisition, the chief financial officer now owns 266,744 shares of the […]

BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript - Vimarsana News

BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript

BCRX earnings call for the period ending March 31, 2024.

Source: fool.com
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2023 Earnings Call Transcript - Vimarsana News

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2023 Earnings Call Transcript

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2023 Earnings Call Transcript February 26, 2024 BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.28 EPS, expectations were $-0.24. BioCryst Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]

Source: yahoo.com